SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.260
AS - Asia 14.738
EU - Europa 8.356
SA - Sud America 2.901
AF - Africa 289
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 51.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.571
SG - Singapore 6.646
CN - Cina 3.533
BR - Brasile 2.438
DE - Germania 1.865
IT - Italia 1.802
HK - Hong Kong 1.518
VN - Vietnam 1.003
GB - Regno Unito 799
FI - Finlandia 775
UA - Ucraina 702
TR - Turchia 571
PL - Polonia 473
RU - Federazione Russa 422
SE - Svezia 365
ID - Indonesia 361
MX - Messico 314
CA - Canada 313
FR - Francia 271
IN - India 268
NL - Olanda 192
AR - Argentina 178
JP - Giappone 172
ES - Italia 140
BD - Bangladesh 134
ZA - Sudafrica 129
AT - Austria 122
BE - Belgio 93
IQ - Iraq 88
EC - Ecuador 80
LT - Lituania 68
PK - Pakistan 59
CO - Colombia 56
KR - Corea 56
CZ - Repubblica Ceca 49
AU - Australia 45
EG - Egitto 39
IE - Irlanda 39
VE - Venezuela 39
CH - Svizzera 37
UZ - Uzbekistan 36
IR - Iran 33
CL - Cile 31
MA - Marocco 30
PY - Paraguay 29
AE - Emirati Arabi Uniti 27
UY - Uruguay 22
JO - Giordania 21
KE - Kenya 20
MY - Malesia 20
PE - Perù 20
SA - Arabia Saudita 18
TW - Taiwan 18
DK - Danimarca 17
AL - Albania 16
AZ - Azerbaigian 15
DZ - Algeria 15
TH - Thailandia 15
TN - Tunisia 15
JM - Giamaica 14
IL - Israele 13
KG - Kirghizistan 13
PT - Portogallo 13
SN - Senegal 12
KZ - Kazakistan 11
LB - Libano 11
NP - Nepal 11
RS - Serbia 11
DO - Repubblica Dominicana 10
RO - Romania 10
HR - Croazia 9
OM - Oman 9
PA - Panama 9
PS - Palestinian Territory 9
BG - Bulgaria 8
NI - Nicaragua 8
PH - Filippine 8
CY - Cipro 7
ET - Etiopia 7
XK - ???statistics.table.value.countryCode.XK??? 7
BH - Bahrain 6
LI - Liechtenstein 6
MD - Moldavia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
BN - Brunei Darussalam 5
HU - Ungheria 5
MK - Macedonia 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
CG - Congo 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
EU - Europa 4
GY - Guiana 4
LV - Lettonia 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
BW - Botswana 3
GT - Guatemala 3
Totale 51.546
Salva come PNG Salva come JPEG
Città #
Singapore 3.651
Ashburn 3.221
Fairfield 2.306
Woodbridge 1.817
Hong Kong 1.491
Santa Clara 1.373
Dallas 1.320
Beijing 1.266
Houston 1.226
Chandler 1.034
Munich 1.028
Seattle 979
Wilmington 853
Ann Arbor 809
Cambridge 767
Jacksonville 761
Los Angeles 592
New York 547
Warsaw 448
Helsinki 395
Ferrara 345
Ho Chi Minh City 343
Izmir 341
Princeton 326
Jakarta 288
Nanjing 271
São Paulo 270
Shanghai 266
Milan 231
San Diego 207
Mexico City 197
Turku 187
Hanoi 186
London 173
Chicago 169
Tokyo 153
Boardman 143
Bologna 126
Brooklyn 121
Hefei 121
Denver 117
Orem 112
Buffalo 111
Montreal 109
Nuremberg 109
Frankfurt am Main 96
Rio de Janeiro 93
Boston 92
Chennai 92
Brussels 91
Moscow 91
Phoenix 90
Toronto 90
Stockholm 89
Atlanta 86
Bremen 80
Poplar 78
Shenyang 78
Tianjin 76
Johannesburg 75
San Francisco 75
Falkenstein 73
Nanchang 72
Rome 70
The Dalles 66
Redwood City 64
Falls Church 63
Amsterdam 62
Washington 62
Council Bluffs 59
Manchester 59
Jiaxing 55
Belo Horizonte 52
Columbus 51
Ankara 50
Haiphong 50
Mumbai 48
San Jose 47
Salt Lake City 45
Changsha 44
Mountain View 44
Lappeenranta 43
Hebei 40
Dong Ket 39
Brasília 38
Querétaro 37
Redondo Beach 37
Ottawa 36
Vienna 36
Addison 34
Da Nang 34
San Mateo 34
Biên Hòa 32
Dublin 32
Goiânia 32
Guangzhou 32
Norwalk 32
Dhaka 31
Assago 30
Jinan 30
Totale 34.073
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 954
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 387
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 379
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 338
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 328
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 327
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 301
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 280
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 263
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 259
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 257
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 255
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 252
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 247
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 240
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 234
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 231
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 230
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 229
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 226
Poor response to clopidogrel: current and future options for its management 225
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 217
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 216
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 210
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 210
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 208
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 208
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 208
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 207
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 206
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 206
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 202
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 202
Mechanistic role of mPTP in ischemia-reperfusion injury 200
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 197
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 196
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 194
Characterization of Dermal Stem Cells of Diabetic Patients 191
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 190
The Mitochondrial Permeability Transition Pore 189
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Can we improve myocardial protection during ischaemic injury? 186
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 186
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 185
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 182
BRS implantation in long lesions requiring device overlapping: Myth or reality? 181
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 181
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 180
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 179
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 176
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 176
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 176
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 176
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 175
The in vitro effects of verbascoside on human platelet aggregation 174
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 174
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 174
Notch Signaling Regulates Immune Responses in Atherosclerosis 173
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 172
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 171
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 171
Reperfusion Damage - A Story of Success, Failure, and Hope 171
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 171
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 170
Fractional flow reserve: Current applications and overview of the available data 169
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 168
A serum proteome signature to predict mortality in severe COVID-19 patients 168
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 167
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 166
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 166
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 166
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 165
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 165
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 164
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention 163
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 163
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 163
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 162
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 162
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 161
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 161
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 159
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 158
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 157
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry 157
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 156
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 155
Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche Emilia-Romagna registry) 155
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 155
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 155
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 155
Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions 154
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 154
Fractional flow reserve implementation in daily clinical practice: A European survey 152
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 152
Specific properties and effect of perindopril in controlling the renin-angiotensin system 151
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 149
Totale 20.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 284.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.921
Totale 286.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.467 0 0 0 0 0 300 166 498 174 541 536 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/202512.666 313 330 920 586 1.425 1.211 806 708 2.320 1.302 1.514 1.231
2025/202618.088 2.969 1.574 3.299 3.858 4.751 1.637 0 0 0 0 0 0
Totale 52.830